Last updated: about 1 month ago
AstraZeneca PLC's SEC Form 6-K: March 2025 Executive Share Vesting Insights
Explore AstraZeneca's March 2025 SEC filing detailing CEO Pascal Soriot's share vesting and compliance with EU regulations. Key insights into executive compensation and performance metrics.